New Enterprise Associates
Edit

New Enterprise Associates

https://www.nea.com
Last activity: 17.10.2025
Active
Invests in categories: PlatformDataHealthTechTechnologyServiceProductMedTechSoftwareFinTechIT
New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With more than $20 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions since its founding in 1977. In the U.S., NEA has offices in Menlo Park, CA; Boston, MA; New York, NY; San Francisco, CA; and the Washington, D.C. metropolitan area. For additional information, visit www.nea.com.
Likes
5.22K
Followers
50.01K
Portfolio
723
Persons
17
Mentions
1.35K
Location: United States, California, Palo Alto
Employees: 51-200
Phone:+1 650-854-9499
Founded date: 1977
Investment Type: Venture Capital
Investment Stage: Seed; Series A; Series B; Series C; Series D; Series E; Series F; IPO; Grant

Portfolio 723

DateNameWebsiteTotal RaisedLocation
11.10.2025QuoteWellquotewell.com$27MUnited Sta...
30.09.2025Zaniazania.ai$18MUnited Sta...
25.09.2025Floxflox.dev$25MUnited Sta...
22.09.2025Avenzo The...avenzotx.com$210MUnited Sta...
11.09.2025cusp.aicusp.ai$100MUnited Kin...
11.09.2025Mojo Visio...mojovision.com$120MUnited Sta...
02.09.2025CHARM Ther...charmtx.com$130.11MUnited Kin...
07.08.2025Elionelion.ai$9.3MUnited Sta...
06.08.2025Elionelion.health$12.6MUnited Sta...
30.07.2025Eleven Lab...elevenlabs.io$531.15MUnited Kin...
Show more

Persons 17

DateFirst NameLast NameTitleLinkedInLocation
-MichaelLi-linkedin.c...-
-BrookeSeawell--
-PeterSonsini--
-ScottGottlieb, ...-linkedin.c...United Sta...
-CarmenChang-linkedin.c...-
-MohamadMakhzoumi--
-ScottSandell--
-ColinBryant-linkedin.c...-
-TonyFlorence--
-PaulWalker--
Show more

Mentions in press and media 1345

DateTitleDescription
17.10.2025Affinia Therapeutics: $40 Million Series C Raised For Advancing Gene Therapies For Cardiovascular And Neurological DiseasesAffinia Therapeutics, a biotechnology company pioneering engineered adeno-associated virus (AAV) gene therapies for severe cardiovascular and neurological conditions, has announced the closing of a $40 million Series C financing round. The ...
13.10.2025QuoteWell Raises $12 Million: AI-Powered Brokerage Targets Commercial Risk MarketQuoteWell, an Austin-based wholesale insurance brokerage, just secured an additional $12 million in funding, bringing its total capital to $32 million. The investment propels its AI-driven platform and expands its footprint in commercial in...
13.10.2025Zania Secures $18M to Transform Enterprise GRC with Agentic AIZania, a San Francisco-based agentic AI innovator, secured $18 million in an oversubscribed Series A funding round led by New Enterprise Associates. The capital fuels aggressive expansion, tripling engineering and go-to-market teams. Zania'...
12.10.2025Zania: $18 Million Series A Raised For GRC PlatformZania, a forward-thinking company focused on agentic AI solutions for security governance, risk, and compliance (GRC), has recently announced the closure of an $18 million Series A funding round. This round was led by New Enterprise Associa...
11.10.2025QuoteWell: $12 Million Secured For Advancing Commercial Insurance Wholesale BrokerageQuoteWell, a technology-driven wholesale insurance brokerage, has recently secured an additional $12 million in financing, which brings the total capital raised by the company to $32 million. This funding is intended to enhance the company’...
09.10.2025AviadoBio and UgeneX Therapeutics Announce Exclusive Option-License Agreement to Develop Next Generation Optogenetics Gene Therapy to Restore Vision in Patients with Retinal DiseaseLONDON, and SHANGHAI – October 9, 2025 – AviadoBio Ltd. (“AviadoBio”), and UgeneX Therapeutics, today announced an exclusive option and license agreement for the development and commercialization of UGX-202, an investigational, AAV-based ge...
08.10.2025QuoteWell raises $12 millionWholesale insurance brokerage QuoteWell QuoteWell Founded: 2021 Headquarters: Austin, Texas, United States Total Funding: $27M See full company profile "> announced an additional $12 million in financing, bringing the company’s tota...
08.10.2025Affinia Therapeutics Raises $40M in Series C FinancingAffinia Therapeutics, a Waltham, MA-based gene therapy company with a pipeline of first-in-class and/or adeno-associated virus (AAV) gene therapies for devastating cardiovascular and neurological diseases, raised $40M in Series C financing....
08.10.2025QuoteWell Raises Additional $12M in FundingQuoteWell, an Austin, TX-based tech-driven wholesale insurance brokerage, raised additional $12M in funding. The round was led by New Enterprise Associates, with participation from new investors Brand Foundry Ventures, ClockTower Ventures a...
03.10.2025Avenzo Therapeutics Secures $60 Million Series B to Advance Oncology BreakthroughsAvenzo Therapeutics secured $60 million in Series B funding. This propels their oncology pipeline. The San Diego biotech now totals $446 million raised. OrbiMed and SR One led the round. New investor Longwood Fund joined. Key existing backe...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In